SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-14-000681
Filing Date
2014-04-22
Accepted
2014-04-22 12:31:41
Documents
4
Period of Report
2014-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v375204_6k.htm 6-K 12471
2 EXHIBIT 99.1 v375204_ex99-1.htm EX-99.1 535729
3 EXHIBIT 99.2 v375204_ex99-2.htm EX-99.2 300853
4 EXHIBIT 99.3 v375204_ex99-3.htm EX-99.3 20188
  Complete submission text file 0001279569-14-000681.txt   870525
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7 416-798-1200
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 14775735
SIC: 2836 Biological Products, (No Diagnostic Substances)